Literature DB >> 23234313

Influence of surface groups on poly(propylene imine) dendrimers antiprion activity.

James M McCarthy1, Beatriz Rasines Moreno, Damien Filippini, Hartmut Komber, Marek Maly, Michaela Cernescu, Bernhard Brutschy, Dietmar Appelhans, Mark S Rogers.   

Abstract

Prion diseases are characterized by the accumulation of PrP(Sc), an aberrantly folded isoform of the host protein PrP(C). Specific forms of synthetic molecules known as dendrimers are able to eliminate protease-resistant PrP(Sc) in both an intracellular and in vitro setting. The properties of a dendrimer which govern this ability are unknown. We addressed the issue by comparing the in vitro antiprion ability of numerous modified poly(propylene-imine) dendrimers, which varied in size, structure, charge, and surface group composition. Several of the modified dendrimers, including an anionic glycodendrimer, reduced the level of protease resistant PrP(Sc) in a prion strain-dependent manner. This led to the formulation of a new working model for dendrimer/prion interactions which proposes dendrimers eliminate PrP(Sc) by destabilizing the protein and rendering it susceptible to proteolysis. This ability is not dependent on any particular charge of dendrimer, but does require a high density of reactive surface groups.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23234313     DOI: 10.1021/bm301165u

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  11 in total

1.  Native nanodiscs formed by styrene maleic acid copolymer derivatives help recover infectious prion multimers bound to brain-derived lipids.

Authors:  Mansoore Esmaili; Brian P Tancowny; Xiongyao Wang; Audric Moses; Leonardo M Cortez; Valerie L Sim; Holger Wille; Michael Overduin
Journal:  J Biol Chem       Date:  2020-05-01       Impact factor: 5.157

2.  Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency.

Authors:  Matthias Schmitz; Niccolo Candelise; Eirini Kanata; Franc Llorens; Katrin Thüne; Anna Villar-Piqué; Susana Margarida da Silva Correia; Dimitra Dafou; Theodoros Sklaviadis; Dietmar Appelhans; Inga Zerr
Journal:  Mol Neurobiol       Date:  2019-12-17       Impact factor: 5.590

3.  Effect of poly-L-arginine in inhibiting scrapie prion protein of cultured cells.

Authors:  Muhammad Waqas; Hye-Mi Lee; Jeeyoung Kim; Glenn Telling; Jin-Ki Kim; Dae-Hwan Kim; Chongsuk Ryou
Journal:  Mol Cell Biochem       Date:  2017-01-07       Impact factor: 3.396

4.  Nanomedicine for prion disease treatment: new insights into the role of dendrimers.

Authors:  James M McCarthy; Dietmar Appelhans; Jörg Tatzelt; Mark S Rogers
Journal:  Prion       Date:  2013 May-Jun       Impact factor: 3.931

5.  A Single Subcutaneous Injection of Cellulose Ethers Administered Long before Infection Confers Sustained Protection against Prion Diseases in Rodents.

Authors:  Kenta Teruya; Ayumi Oguma; Keiko Nishizawa; Maki Kawata; Yuji Sakasegawa; Hiroshi Kamitakahara; Katsumi Doh-Ura
Journal:  PLoS Pathog       Date:  2016-12-14       Impact factor: 6.823

6.  Brain Delivery of Multifunctional Dendrimer Protein Bioconjugates.

Authors:  Pierpaolo Moscariello; David Y W Ng; Malin Jansen; Tanja Weil; Heiko J Luhmann; Jana Hedrich
Journal:  Adv Sci (Weinh)       Date:  2018-02-23       Impact factor: 16.806

7.  Cationic Carbosilane Dendrimers Prevent Abnormal α-Synuclein Accumulation in Parkinson's Disease Patient-Specific Dopamine Neurons.

Authors:  Raquel Ferrer-Lorente; Tania Lozano-Cruz; Irene Fernández-Carasa; Katarzyna Miłowska; Francisco Javier de la Mata; Maria Bryszewska; Antonella Consiglio; Paula Ortega; Rafael Gómez; Angel Raya
Journal:  Biomacromolecules       Date:  2021-10-06       Impact factor: 6.988

8.  Synthesis and Characterization of Cationic Dendrimer-PDMS Hybrids.

Authors:  Monica A Marks; Kyriaki Kalaitzidou; Will R Gutekunst
Journal:  Macromol Rapid Commun       Date:  2020-12-28       Impact factor: 5.734

Review 9.  Dendrimer-Based Drug Delivery Systems for Brain Targeting.

Authors:  Yuefei Zhu; Chunying Liu; Zhiqing Pang
Journal:  Biomolecules       Date:  2019-11-27

10.  DOTA Glycodendrimers as Cu(II) Complexing Agents and Their Dynamic Interaction Characteristics toward Liposomes.

Authors:  Marianna Carone; Silvia Moreno; Michela Cangiotti; Maria Francesca Ottaviani; Peng Wang; Riccardo Carloni; Dietmar Appelhans
Journal:  Langmuir       Date:  2020-10-20       Impact factor: 3.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.